Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man.
about
The role of platelet activating factor in allergic respiratory diseaseScreening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida BiofilmsPreclinical and clinical pharmacology of platelet-activating factor receptor antagonists.Does upregulated host cell receptor expression provide a link between bacterial adhesion and chronic respiratory disease?Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
P2860
Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Effectiveness and tolerability ...... avenous administration to man.
@en
Effectiveness and tolerability ...... avenous administration to man.
@nl
type
label
Effectiveness and tolerability ...... avenous administration to man.
@en
Effectiveness and tolerability ...... avenous administration to man.
@nl
prefLabel
Effectiveness and tolerability ...... avenous administration to man.
@en
Effectiveness and tolerability ...... avenous administration to man.
@nl
P2093
P2860
P1476
Effectiveness and tolerability ...... avenous administration to man.
@en
P2093
De Lepeleire I
De Schepper P
Miyamoto Y
Vermylen J
van Hecken A
P2860
P304
P356
10.1111/J.1365-2125.1988.TB03328.X
P407
P577
1988-04-01T00:00:00Z